AAAAAA

   
Results: 1-7 |
Results: 7

Authors: STARK H HULS A LIGNEAU X PURAND K PERTZ H ARRANG JM SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., DEVELOPMENT OF FUB-181, A SELECTIVE HISTAMINE H-3-RECEPTOR ANTAGONISTOF HIGH ORAL IN-VIVO POTENCY WITH 4-(OMEGA-(ARYLALKYLOXY)ALKYL)-1H-IMIDAZOLE STRUCTURE, Archiv der pharmazie, 331(6), 1998, pp. 211-218

Authors: HULS A PURAND K STARK H LIGNEAU X ARRANG JM SCHWARTZ JC SCHUNACK W
Citation: A. Huls et al., DIPHENYLMETHYL ETHERS - SYNTHESIS AND HISTAMINE H-3 RECEPTOR ANTAGONIST IN-VITRO AND IN-VIVO ACTIVITY, Bioorganic & medicinal chemistry letters, 6(16), 1996, pp. 2013-2018

Authors: HULS A PURAND K STARK H REIDEMEISTER S LIGNEAU X ARRANG JM SCHWARTZ JC SCHUNACK W
Citation: A. Huls et al., NOVEL HISTAMINE H-3 RECEPTOR ANTAGONISTS WITH BENZYL ETHER STRUCTURE OR RELATED MOIETIES - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS, Archiv der pharmazie, 329(8-9), 1996, pp. 379-385

Authors: STARK H PURAND K HULS A LIGNEAU X GARBARG M SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., [I-125] IODOPROXYFAN AND RELATED-COMPOUNDS - A REVERSIBLE RADIOLIGANDAND NOVEL CLASSES OF ANTAGONISTS WITH HIGH-AFFINITY AND SELECTIVITY FOR THE HISTAMINE HS RECEPTOR, Journal of medicinal chemistry, 39(6), 1996, pp. 1220-1226

Authors: STARK H PURAND K LIGNEAU X ROULEAU A ARRANG JM GARBARG M SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., NOVEL CARBAMATES AS POTENT HISTAMINE H-3 RECEPTOR ANTAGONISTS WITH HIGH IN-VITRO AND ORAL IN-VIVO ACTIVITY, Journal of medicinal chemistry, 39(5), 1996, pp. 1157-1163

Authors: SCHLICKER E PERTZ H BITSCHNAU H PURAND K KATHMANN M ELZ S SCHUNACK W
Citation: E. Schlicker et al., EFFECTS OF IODOPROXYFAN, A POTENT AND SELECTIVE HISTAMINE H-3 RECEPTOR ANTAGONIST, ON ALPHA(2) AND 5-HT3 RECEPTORS, Inflammation research, 44(7), 1995, pp. 296-300

Authors: LIGNEAU X GARBARG M VIZUETE ML DIAZ J PURAND K STARK H SCHUNACK W SCHWARTZ JC
Citation: X. Ligneau et al., [I-125] IODOPROXYFAN, A NEW ANTAGONIST TO LABEL AND VISUALIZE CEREBRAL HISTAMINE H-3 RECEPTORS, The Journal of pharmacology and experimental therapeutics, 271(1), 1994, pp. 452-459
Risultati: 1-7 |